 SOUTH SAN FRANCISCO, Calif., June 02, 2022 GLOBE NEWSWIRE -- Cytokinetics, Incorporated Nasdaq: CYTK today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in the following investor conferences: 